The federal contract IDV award to Diasorin Inc., a foreign-owned for-profit medical diagnostics company, is a $10 million Federal Supply Schedule (FSS) contract from the Department of Veterans Affairs (VA). The contract, with a period of performance through March 2030, is for the provision of cost-per-test clinical laboratory analyzers and associated services.
Diasorin Inc. is the prime contractor, with its parent company Diasorin S.P.A. providing overall corporate support. The contract provides VA medical facilities nationwide with access to Diasorin's LIAISON XL and LIAISON XS chemiluminescence immunoassay analyzers, as well as related reagents, consumables, and technical support for infectious disease testing capabilities, including COVID-19, tuberculosis, varicella, and cytomegalovirus. This comprehensive diagnostic solution supports critical healthcare needs across the VA system. The contract was awarded without any set-aside designations, reflecting Diasorin's specialized technological capabilities. Diasorin has also secured several significant Indefinite Delivery Vehicles (IDVs) with the VA and Department of Defense to efficiently deliver its diagnostic products and services to federal healthcare providers.
Generated 3/21/25, 9:49 AM